C57BL/6N-Hprt1tm1a(EUCOMM)Hmgu/Ieg

Status

Available to order

EMMA IDEM:04718
International strain nameC57BL/6N-Hprt1tm1a(EUCOMM)Hmgu/Ieg
Alternative nameHEPD0543_8_G03
Strain typeTargeted Mutant Strains
Allele/Transgene symbolHprt1tm1a(EUCOMM)Hmgu
Gene/Transgene symbolHprt1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Provider affiliationInstitute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Genetic informationThis mouse line originates from EUCOMM ES clone HEPD0543_8_G03. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6NTac, wild-type C57BL/6NTac
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (allele matching)
  • abnormal gait / IMPC
  • increased circulating HDL cholesterol level / IMPC
  • increased mean corpuscular volume / IMPC
  • decreased erythrocyte cell number / IMPC
  • thrombocytopenia / IMPC
IMPC phenotypes (gene matching)
  • increased mean corpuscular volume / IMPC
  • thrombocytopenia / IMPC
  • increased circulating HDL cholesterol level / IMPC
  • decreased erythrocyte cell number / IMPC
  • abnormal gait / IMPC
MGI phenotypes (gene matching)
  • decreased hematocrit / MGI
  • increased leukocyte cell number / MGI
  • increased neutrophil cell number / MGI
  • abnormal small intestine morphology / MGI
  • abnormal liver morphology / MGI
  • abnormal branching of the mammary ductal tree / MGI
  • enlarged spleen / MGI
  • spleen hyperplasia / MGI
  • enlarged lymph nodes / MGI
  • tremors / MGI
  • convulsive seizures / MGI
  • abnormal lung morphology / MGI
  • decreased body weight / MGI
  • decreased anxiety-related response / MGI
  • ataxia / MGI
  • hypoactivity / MGI
  • impaired coordination / MGI
  • abnormal gait / MGI
  • short stride length / MGI
  • decreased exploration in new environment / MGI
  • limb grasping / MGI
  • abnormal motor coordination/balance / MGI
  • abnormal hematopoietic system physiology / MGI
  • hyperglycemia / MGI
  • anemia / MGI
  • cardiac hypertrophy / MGI
  • increased mammary adenocarcinoma incidence / MGI
  • abnormal reflex / MGI
  • seizures / MGI
  • abnormal motor capabilities/coordination/movement / MGI
  • premature death / MGI
  • abnormal definitive hematopoiesis / MGI
  • abnormal brain morphology / MGI
  • no abnormal phenotype detected / MGI
  • neurodegeneration / MGI
  • abnormal spleen white pulp morphology / MGI
  • abnormal hematopoietic system morphology/development / MGI
  • abnormal megakaryocyte progenitor cell morphology / MGI
  • hepatic steatosis / MGI
  • decreased vertical activity / MGI
  • increased heart weight / MGI
  • increased systemic arterial blood pressure / MGI
  • albuminuria / MGI
  • decreased erythrocyte cell number / MGI
  • increased urine protein level / MGI
  • impaired social transmission of food preference / MGI
  • no phenotypic analysis / MGI
  • phenotypic reversion / MGI
  • abnormal dopaminergic neuron morphology / MGI
  • astrocytosis / MGI
  • abnormal depression-related behavior / MGI
  • decreased tumor growth/size / MGI
  • abnormal nervous system morphology / MGI
  • abnormal cardiac muscle relaxation / MGI
  • neuronal intranuclear inclusions / MGI
  • abnormal myocardial fiber physiology / MGI
  • abnormal Paneth cell morphology / MGI
  • decreased B cell number / MGI
  • decreased cardiac muscle contractility / MGI
  • glomerulosclerosis / MGI
  • abnormal podocyte morphology / MGI
  • muscle phenotype / MGI
  • homeostasis/metabolism phenotype / MGI
  • endocrine/exocrine gland phenotype / MGI
  • behavior/neurological phenotype / MGI
  • immune system phenotype / MGI
  • taste/olfaction phenotype / MGI
  • hematopoietic system phenotype / MGI
  • jerky movement / MGI
  • thrombocytosis / MGI
  • decreased ventricle muscle contractility / MGI
  • decreased mean corpuscular hemoglobin concentration / MGI
  • decreased dopamine level / MGI
  • abnormal podocyte slit diaphragm morphology / MGI
  • absent podocyte slit diaphragm / MGI
  • podocyte foot process effacement / MGI
  • increased megakaryocyte cell number / MGI
  • abnormal spatial reference memory / MGI
  • abnormal spatial working memory / MGI
  • abnormal splenic cell ratio / MGI
  • abnormal physiological response to xenobiotic / MGI
  • abnormal enterocyte proliferation / MGI
  • abnormal enterocyte apoptosis / MGI
  • abnormal neuron differentiation / MGI
  • increased mammary gland tumor incidence / MGI
  • myeloid hyperplasia / MGI
  • expanded mesangial matrix / MGI
  • mesangial cell hyperplasia / MGI
  • abnormal habituation to a new environment / MGI
  • abnormal ceramide level / MGI
  • decreased brain choline acetyltransferase activity / MGI
  • decreased brain tyrosine 3-monooxygenase activity / MGI
  • decreased vascular endothelial cell proliferation / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).